News and communications

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine rozanolixizumab (Rystiggo) to treat adults with generalised myasthenia gravis, an autoimmune disease that causes m…

• Updated: 7 March 2024

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (6 March 2024) approved the medicine piflufolastat (18F) (Pylclari) as a diagnostic tool for people with suspected or known prostate cancer.

• Updated: 6 March 2024

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (6 March 2024) approved the Rubidium (Rb82) Generator (RUBY-FILL) as a diagnostic tool for imaging of the heart, to evaluate blood flow and aid in the …

• Updated: 6 March 2024

Launched in January 2024, IRP aims to further help bring life-saving new medicines to UK patients without delay

• Updated: 1 March 2024

Process changes from 1 March 2024 build on measures already implemented by the agency

• Updated: 28 February 2024

Dame June Raine, MHRA's Chief Executive, will be stepping down in the Autumn following five years in the role

• Updated: 26 February 2024

Millions invested in eight innovative companies behind lifesaving new medical technology which could destroy liver cancer tumours, detect Alzheimer’s and quickly spot those at risk of stroke

• Updated: 21 February 2024

People are urged to seek advice from healthcare professionals if they feel they have become dependent on or addicted to codeine linctus.

• Updated: 20 February 2024

The MHRA has reviewed the latest evidence relating to the very rare risk of PRES and RCVS associated with medicines containing pseudoephedrine

• Updated: 20 February 2024

The Yellow Card Biobank will today start investigating a new group of medicines known as Direct Oral Anticoagulants

• Updated: 13 February 2024

Approval of a change to the licence of Comirnaty COVID-19 vaccine will enable thawing and re-labelling of the vaccine outside of the NHS

• Updated: 9 February 2024

The Medicines and Healthcare products Regulatory Agency (MHRA) has designated two new UK Approved Bodies, delivering increased capacity for the certification of the performance and safety of medical devices, for healthcare p…

• Updated: 31 January 2024

No one should stop taking valproate without advice from their healthcare professional

• Updated: 31 January 2024

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (30 January 2024) approved the medicine momelotinib (Omjjara) to treat the symptoms experienced by adult myelofibrosis patients who have moderate or se…

• Updated: 31 January 2024

The Medicines and Healthcare products Regulatory Agency (MHRA), working with law enforcement partners, seized more than 15.5 million doses of illegally traded medicines with a street value of more than £30 million during 202…

• Updated: 30 January 2024

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (29 January 2024) approved the medicine Rezzayo (rezafungin) to treat a fungal infection called invasive candidiasis.

• Updated: 29 January 2024

The new presentation of Mounjaro gives four doses for once-a-week treatment over a month.

• Updated: 25 January 2024

Half a million women in England have accessed cheaper HRT - the main treatment for negative menopause symptoms - since last April.

• Updated: 24 January 2024

Do not stop your hypertriglyceridemia treatment without a discussion with your doctor

• Updated: 22 January 2024

Following a review of the effectiveness of current measures to reduce the risk of potentially long-term or irreversible side effects associated with fluoroquinolone antibiotics, the MHRA has introduced further restrictions t…

• Updated: 22 January 2024